Risk of venous thromboembolism (VTE) in breast cancer patients receiving erythropoietin for chemotherapy-induced anemia: A Tertiary Cancer Center experience from the University of Arkansas for Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback